UCHEALTH GRANDVIEW HOSPITAL — History
CCN 060130 | 3-year financial timeline | COVID resilience: 53/100
🛡️ Public data only — no PHI permitted on this instance.
$43M
Latest Revenue (FY2022)
+4.5%
Revenue CAGR (3yr)
-13.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $40M | $44M | $43M | -1.8% | +4.5% |
| Operating Expenses | $45M | $49M | $49M | +1.3% | +5.1% |
| Operating Margin | -11.8% | -9.7% | -13.2% | -35.5% | +0.0% |
| Net Income | $-5M | $-4M | $-6M | -33.0% | +0.0% |
| Licensed Beds | 22 | 22 | 22 | +0.0% | +0.0% |
| Total Patient Days | 2,274 | 2,407 | 1,256 | -47.8% | -25.7% |
| Medicare Day % | 40% | 31% | 28% | -9.8% | -16.8% |
| Medicaid Day % | 15% | 20% | 19% | -5.4% | +10.8% |
COVID Impact & Recovery
Resilience Score: 53/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +9.1% ($40M → $43M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.5%
This Hospital
+7.6%
State Avg
Latest Margin
-13.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $45M | -13.9% |
| FY2024 (proj) | $47M | -14.5% |
| FY2025 (proj) | $49M | -15.2% |